Regeneron Pharmaceuticals, Inc. (FRA:RGO)

Regeneron Pharmaceuticals Employees

Regeneron Pharmaceuticals had 15,222 employees as of September 30, 2025. The number of employees increased by 1,057 or 7.46% compared to the same quarter last year.

• Employees: 15,222
• Change: 1,057
• Growth: 7.46%
• Revenue / Employee: €802,513
• Profits / Employee: €252,058
• Market Cap: 64.03B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Sep 30, 2025	15,222	1,057	7.46%
Jun 30, 2025	15,182	1,256	9.02%
Mar 31, 2025	15,158	1,481	10.83%
Dec 31, 2024	15,106	1,656	12.31%
Sep 30, 2024	14,165	1,702	13.66%
Jun 30, 2024	13,926	1,670	13.63%
Mar 31, 2024	13,677	1,578	13.04%
Dec 31, 2023	13,450	1,599	13.49%
Sep 30, 2023	12,463	1,548	14.18%
Jun 30, 2023	12,256	1,541	14.38%
Mar 31, 2023	12,099	1,607	15.32%
Dec 31, 2022	11,851	1,483	14.30%
Sep 30, 2022	10,915	1,149	11.77%
Jun 30, 2022	10,715	1,080	11.21%
Mar 31, 2022	10,492	1,045	11.06%
Dec 31, 2021	10,368	1,245	13.65%
Sep 30, 2021	9,766	1,452	17.46%
Jun 30, 2021	9,635	1,493	18.34%
Mar 31, 2021	9,447	1,417	17.65%